Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EKGuard is a medical device company focused on improving the quality of life and safety for patients undergoing peritoneal dialysis. The company's flagship product, the EKGuard, is a specialized catheter stabilization and exit site protection device designed to prevent catheter tugging, reduce the risk of exit-site infections, and eliminate the need for adhesive tapes. By providing a secure and comfortable housing for the catheter, EKGuard helps maintain the integrity of the exit site and simplifies daily care for dialysis patients. The company was founded by a healthcare professional to address unmet needs in home-based renal care and currently markets its solutions to dialysis centers and individual patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on E.K.Guard.